FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808672871> ?p ?o ?g. }

• W2808672871 endingPage "e000637" @default.
• W2808672871 startingPage "e000637" @default.
• W2808672871 abstract "To evaluate long-term clinical, functional and radiographic outcomes in an open-label extension (OLE) study in patients with rheumatoid arthritis (RA) receiving adalimumab monotherapy or adalimumab+methotrexate following attainment of low disease activity (LDA) with adalimumab+methotrexate.Methotrexate-naive patients with early RA were randomised to adalimumab, methotrexate or adalimumab +methotrexate in a double-blind, 2-year study. Patients who completed the study and achieved LDA (28-joint Disease Activity Score using C reactive protein (DAS28(CRP)<3.2) could receive adalimumab monotherapy for up to 8 additional years in the OLE; open-label methotrexate could be added per investigator's discretion. This post hoc analysis included data up to OLE year 3 (study year 5) from patients receiving adalimumab+methotrexate who achieved LDA at year 2 followed by adalimumab monotherapy or methotrexate reinitiation. Normal physical function was defined as Disability Index of the Health Assessment Questionnaire <0.5 and radiographic non-progression as change in modified total Sharp score ≤0.5.Of 140 patients initiating adalimumab monotherapy, 84 (60%) received adalimumab only (methotrexate non-use) and 56 (40%) reinitiated methotrexate (methotrexate use) during OLE treatment. Median (IQR) time to first methotrexate use was 5.1 (0.1-31.4) weeks. Among methotrexate users, 61% retained LDA, 48% achieved DAS28(CRP) <2.6, 45% had normal physical function and 46% had no radiographic progression at year 5; for non-users, 63%, 50%, 58% and 50%, respectively, achieved these milestones. Adverse event rates were similar between methotrexate non-use and use patients.Adalimumab monotherapy effectively maintained good clinical, functional and radiographic outcomes for up to 3 additional years in ≥50% of patients who attained LDA after 2 years of adalimumab+methotrexate therapy.NCT00195663; Post-results." @default.
• W2808672871 created "2018-06-21" @default.
• W2808672871 creator A5030598737 @default.
• W2808672871 creator A5052424289 @default.
• W2808672871 creator A5057287761 @default.
• W2808672871 creator A5059585172 @default.
• W2808672871 creator A5079625006 @default.
• W2808672871 creator A5080646462 @default.
• W2808672871 date "2018-06-01" @default.
• W2808672871 modified "2023-09-26" @default.
• W2808672871 title "Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis" @default.
• W2808672871 cites W1966756501 @default.
• W2808672871 cites W1985763670 @default.
• W2808672871 cites W1993923138 @default.
• W2808672871 cites W1996389186 @default.
• W2808672871 cites W1996472975 @default.
• W2808672871 cites W1996927325 @default.
• W2808672871 cites W1999777294 @default.
• W2808672871 cites W2014330392 @default.
• W2808672871 cites W2045085974 @default.
• W2808672871 cites W2111153776 @default.
• W2808672871 cites W2116843833 @default.
• W2808672871 cites W2120143305 @default.
• W2808672871 cites W2120393706 @default.
• W2808672871 cites W2135461594 @default.
• W2808672871 cites W2140219205 @default.
• W2808672871 cites W2141063259 @default.
• W2808672871 cites W2141202105 @default.
• W2808672871 cites W2141719028 @default.
• W2808672871 cites W2141953337 @default.
• W2808672871 cites W2156652067 @default.
• W2808672871 cites W2168729355 @default.
• W2808672871 cites W2170660004 @default.
• W2808672871 cites W2173611899 @default.
• W2808672871 cites W2262131072 @default.
• W2808672871 cites W2292323398 @default.
• W2808672871 cites W2526042914 @default.
• W2808672871 doi "https://doi.org/10.1136/rmdopen-2017-000637" @default.
• W2808672871 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6018859" @default.
• W2808672871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29955381" @default.
• W2808672871 hasPublicationYear "2018" @default.
• W2808672871 type Work @default.
• W2808672871 sameAs 2808672871 @default.
• W2808672871 citedByCount "4" @default.
• W2808672871 countsByYear W28086728712019 @default.
• W2808672871 countsByYear W28086728712021 @default.
• W2808672871 countsByYear W28086728712022 @default.
• W2808672871 countsByYear W28086728712023 @default.
• W2808672871 crossrefType "journal-article" @default.
• W2808672871 hasAuthorship W2808672871A5030598737 @default.
• W2808672871 hasAuthorship W2808672871A5052424289 @default.
• W2808672871 hasAuthorship W2808672871A5057287761 @default.
• W2808672871 hasAuthorship W2808672871A5059585172 @default.
• W2808672871 hasAuthorship W2808672871A5079625006 @default.
• W2808672871 hasAuthorship W2808672871A5080646462 @default.
• W2808672871 hasBestOaLocation W28086728711 @default.
• W2808672871 hasConcept C126322002 @default.
• W2808672871 hasConcept C197934379 @default.
• W2808672871 hasConcept C2777575956 @default.
• W2808672871 hasConcept C2780132546 @default.
• W2808672871 hasConcept C2781059491 @default.
• W2808672871 hasConcept C67761136 @default.
• W2808672871 hasConcept C71924100 @default.
• W2808672871 hasConceptScore W2808672871C126322002 @default.
• W2808672871 hasConceptScore W2808672871C197934379 @default.
• W2808672871 hasConceptScore W2808672871C2777575956 @default.
• W2808672871 hasConceptScore W2808672871C2780132546 @default.
• W2808672871 hasConceptScore W2808672871C2781059491 @default.
• W2808672871 hasConceptScore W2808672871C67761136 @default.
• W2808672871 hasConceptScore W2808672871C71924100 @default.
• W2808672871 hasFunder F4320309117 @default.
• W2808672871 hasIssue "1" @default.
• W2808672871 hasLocation W28086728711 @default.
• W2808672871 hasLocation W28086728712 @default.
• W2808672871 hasLocation W28086728713 @default.
• W2808672871 hasLocation W28086728714 @default.
• W2808672871 hasOpenAccess W2808672871 @default.
• W2808672871 hasPrimaryLocation W28086728711 @default.
• W2808672871 hasRelatedWork W1963607473 @default.
• W2808672871 hasRelatedWork W2095714646 @default.
• W2808672871 hasRelatedWork W2168751860 @default.
• W2808672871 hasRelatedWork W2760739255 @default.
• W2808672871 hasRelatedWork W2793666661 @default.
• W2808672871 hasRelatedWork W2945936762 @default.
• W2808672871 hasRelatedWork W3217041469 @default.
• W2808672871 hasRelatedWork W4256594459 @default.
• W2808672871 hasRelatedWork W4300786425 @default.
• W2808672871 hasRelatedWork W2185841895 @default.
• W2808672871 hasVolume "4" @default.
• W2808672871 isParatext "false" @default.
• W2808672871 isRetracted "false" @default.
• W2808672871 magId "2808672871" @default.
• W2808672871 workType "article" @default.